BJU International

Cover image for Vol. 118 Issue 5

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Prokar Dasgupta

Impact Factor: 4.387

ISI Journal Citation Reports © Ranking: 2015: 10/77 (Urology & Nephrology)

Online ISSN: 1464-410X


  1. 1 - 100
  2. 101 - 108
  1. Original Articles

    1. A randomised controlled trial evaluating renal protective effects of selenium with vitamins A, C, E, verapamil, and losartan against extracorporeal shockwave lithotripsy-induced renal injury

      Ahmed R. El-Nahas, Mohamed M. Elsaadany, Diaa-Eldin Taha, Ahmed M. Elshal, Mohamed Abo El-Ghar, Amani M. Ismail, Essam A. Elsawy, Hazem H. Saleh, Ehab W. Wafa, Amira Awadalla, Tamer S. Barakat and Khaled Z. Sheir

      Version of Record online: 20 OCT 2016 | DOI: 10.1111/bju.13667

    2. A novel infusion-drainage device to assess lower urinary tract function in neuro-imaging

      Lorenz Leitner, Matthias Walter, Behnaz Jarrahi, Johann Wanek, Jörg Diefenbacher, Lars Michels, Martina D. Liechti, Spyros S. Kollias, Thomas M. Kessler and Ulrich Mehnert

      Version of Record online: 20 OCT 2016 | DOI: 10.1111/bju.13655

    3. Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma

      George C. Bailey, Stephen A. Boorjian, Matthew J. Ziegelmann, Mary E. Westerman, Christine M. Lohse, Bradley C. Leibovich, John C. Cheville and R. Houston Thompson

      Version of Record online: 20 OCT 2016 | DOI: 10.1111/bju.13669

    4. Evolution of robot-assisted orthotopic ileal neobladder formation: a step-by-step update to the University of Southern California (USC) technique

      Sameer Chopra, Andre Luis de Castro Abreu, Andre K. Berger, Shuchi Sehgal, Inderbir Gill, Monish Aron and Mihir M. Desai

      Version of Record online: 18 OCT 2016 | DOI: 10.1111/bju.13611

    5. The landscape of systematic reviews in urology (1998 to 2015): an assessment of methodological quality

      Julia L. Han, Shreyas Gandhi, Crystal G. Bockoven, Vikram M. Narayan and Philipp Dahm

      Version of Record online: 17 OCT 2016 | DOI: 10.1111/bju.13653

    6. Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years

      John W. Yaxley, Kevin Lah, Julian P. Yaxley, Robert A. Gardiner, Hema Samaratunga and James MacKean

      Version of Record online: 7 OCT 2016 | DOI: 10.1111/bju.13659

  2. Supplement Articles

    1. Understanding the role of new systemic agents in the treatment of prostate cancer

      Julia Corfield, Jack Crozier, Anthony Joshua, Damien Bolton and Nathan Lawrentschuck

      Version of Record online: 6 OCT 2016 | DOI: 10.1111/bju.13633

  3. Original Articles

    1. Transgenic animal model for studying the mechanism of obesity-associated stress urinary incontinence

      Lin Wang, Guiting Lin, Yung-Chin Lee, Amanda B. Reed-Maldonado, Melissa T. Sanford, Guifang Wang, Huixi Li, Lia Banie, Zhengcheng Xin and Tom F. Lue

      Version of Record online: 5 OCT 2016 | DOI: 10.1111/bju.13661

    2. Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score

      Eugenio Martorana, Giacomo Maria Pirola, Michele Scialpi, Salvatore Micali, Andrea Iseppi, Luca Reggiani Bonetti, Shaniko Kaleci, Pietro Torricelli and Giampaolo Bianchi

      Version of Record online: 4 OCT 2016 | DOI: 10.1111/bju.13649

    3. Is negative multiparametric magnetic resonance imaging really able to exclude significant prostate cancer? The real-life experience

      Nicolas Branger, Thomas Maubon, Miriam Traumann, Jeanne Thomassin-Piana, Nicolas Brandone, Sébastien Taix, Julien Touzlian, Serge Brunelle, Geraldine Pignot, Naji Salem, Gwenaelle Gravis and Jochen Walz

      Version of Record online: 4 OCT 2016 | DOI: 10.1111/bju.13657

    4. Diagnostic accuracy of computed tomography urography and visual assessment during ureterorenoscopy in upper tract urothelial carcinoma

      Alexandra Grahn, Miden Melle-Hannah, Camilla Malm, Fredrik Jäderling, Eva Radecka, Mats Beckman and Marianne Brehmer

      Version of Record online: 3 OCT 2016 | DOI: 10.1111/bju.13652

    5. Qualitative study on decision-making by prostate cancer physicians during active surveillance

      Stacy Loeb, Caitlin Curnyn, Angela Fagerlin, Ronald Scott Braithwaite, Mark D. Schwartz, Herbert Lepor, Herbert Ballentine Carter and Erica Sedlander

      Version of Record online: 2 OCT 2016 | DOI: 10.1111/bju.13651

    6. Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective series

      Mark W. Ball, Kelly T. Harris, Zeyad R. Schwen, Jeffrey K. Mullins, Misop Han, Patrick C. Walsh, Alan W. Partin and Jonathan I. Epstein

      Version of Record online: 30 SEP 2016 | DOI: 10.1111/bju.13654

    7. Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional ‘QoLiTime’ study

      Ralf-Dieter Hofheinz, Carsten Lange, Thorsten Ecke, Susanne Kloss, Burkhard Linsse, Christine Windemuth-Kieselbach, Peter Hammerer and Salah-Eddin Al-Batran

      Version of Record online: 30 SEP 2016 | DOI: 10.1111/bju.13658

  4. Supplement Articles

    1. The Australian laparoscopic non robotic radical prostatectomy experience – analysis of 2943 cases (USANZ supplement)

      Mark William Louie-Johnsun, Marcus M. Handmer, Ross John Spero Calopedos, Charles Chabert, Ronald J. Cohen, Troy R. J. Gianduzzo, Paul A. Kearns, Daniel A. Moon, Jason Ooi, Tom Shannon, David Sofield and Andrew H. H. Tan

      Version of Record online: 23 SEP 2016 | DOI: 10.1111/bju.13610

    2. The use of 68 Ga-PSMA PET CT in men with biochemical recurrence after definitive treatment of acinar prostate cancer

      Greta Meredith, David Wong, John Yaxley, Geoff Coughlin, Les Thompson, Boon Kua and Troy Gianduzzo

      Version of Record online: 23 SEP 2016 | DOI: 10.1111/bju.13616

  5. Original Articles

    1. You have full text access to this OnlineOpen article
      Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer

      Andrew S. McDaniel, Roberta Ferraldeschi, Rachel Krupa, Mark Landers, Ryon Graf, Jessica Louw, Adam Jendrisak, Natalee Bales, Dena Marrinucci, Zafeiris Zafeiriou, Penelope Flohr, Spyridon Sideris, Mateus Crespo, Ines Figueiredo, Joaquin Mateo, Johann S. de Bono, Ryan Dittamore, Scott A. Tomlins and Gerhardt Attard

      Version of Record online: 18 SEP 2016 | DOI: 10.1111/bju.13631

    2. Risk of hospitalisation after primary treatment for prostate cancer

      Stephen B. Williams, Zhigang Duan, Karim Chamie, Karen E. Hoffman, Benjamin D. Smith, Jim C. Hu, Jay B. Shah, John W. Davis and Sharon H. Giordano

      Version of Record online: 16 SEP 2016 | DOI: 10.1111/bju.13647

    3. Laparoscopic retroperitoneal partial nephrectomy using an ergonomic chair: demonstration of technique and matched-pair analysis

      Jens J. Rassweiler, Jan Klein, Alexandra Tschada and Ali Serdar Gözen

      Version of Record online: 12 SEP 2016 | DOI: 10.1111/bju.13627

    4. Perioperative and short-term outcomes of Retzius-sparing robot-assisted laparoscopic radical prostatectomy stratified by gland size

      Glen D.R Santok, Ali Abdel Raheem, Lawrence H. C. Kim, Kidon Chang, Trenton G. H. Lum, Byung H. Chung, Young D. Choi and Koon H. Rha

      Version of Record online: 12 SEP 2016 | DOI: 10.1111/bju.13632

    5. PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database

      Riccardo Schiavina, Giacomo Novara, Marco Borghesi, Vincenzo Ficarra, Rajesh Ahlawat, Daniel A. Moon, Francesco Porpiglia, Benjamin J. Challacombe, Prokar Dasgupta, Eugenio Brunocilla, Gaetano La Manna, Alessandro Volpe, Hema Verma, Giuseppe Martorana and Alexandre Mottrie

      Version of Record online: 11 SEP 2016 | DOI: 10.1111/bju.13628

    6. Serum levels of enclomiphene and zuclomiphene in men with hypogonadism on long-term clomiphene citrate treatment

      Sevann Helo, Joseph Mahon, Joseph Ellen, Ron Wiehle, Gregory Fontenot, Kuang Hsu, Paul Feustel, Charles Welliver and Andrew McCullough

      Version of Record online: 11 SEP 2016 | DOI: 10.1111/bju.13625

    7. The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7–10 prostate cancer in a repeat biopsy setting

      Nienke L. Hansen, Tristan Barrett, Brendan Koo, Andrew Doble, Vincent Gnanapragasam, Anne Warren, Christof Kastner and Ola Bratt

      Version of Record online: 8 SEP 2016 | DOI: 10.1111/bju.13619

    8. Safety, reliability and accuracy of small renal tumour biopsies: results from a multi-institution registry

      Patrick O. Richard, Michael A. S. Jewett, Simon Tanguay, Olli Saarela, Zhihui Amy Liu, Frédéric Pouliot, Anil Kapoor, Ricardo Rendon and Antonio Finelli

      Version of Record online: 7 SEP 2016 | DOI: 10.1111/bju.13630

    9. Randomised trial of early infant circumcision performed by clinical officers and registered nurse midwives using the Mogen clamp in Rakai, Uganda

      Edward N. Kankaka, Teddy Murungi, Godfrey Kigozi, Frederick Makumbi, Dorean Nabukalu, Stephen Watya, Nehemiah Kighoma, Resty Nampijja, Daniel Kayiwa, Fred Nalugoda, David Serwadda, Maria Wawer and Ronald H. Gray

      Version of Record online: 6 SEP 2016 | DOI: 10.1111/bju.13589

    10. Prostate cancer outcomes for men who present with symptoms at diagnosis

      Kerri R. Beckmann, Michael E. O'Callaghan, Rasa Ruseckaite, Ned Kinnear, Caroline Miller, Sue Evans, David M. Roder, Kim Moretti and for the South Australian Prostate Cancer Clinical Outcomes Collaborative

      Version of Record online: 3 SEP 2016 | DOI: 10.1111/bju.13622

    11. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance

      Rodrigo R. Pessoa, Publio C. Viana, Romulo L. Mattedi, Giuliano B. Guglielmetti, Mauricio D. Cordeiro, Rafael F. Coelho, William C. Nahas and Miguel Srougi

      Version of Record online: 3 SEP 2016 | DOI: 10.1111/bju.13624

    12. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes

      Sarah P. Psutka, Mark Heidenreich, Stephen A. Boorjian, George C. Bailey, John C. Cheville, Suzanne B. Stewart-Merrill, Christine M. Lohse, Thomas D. Atwell, Brian A. Costello, Bradley C. Leibovich and R. Houston Thompson

      Version of Record online: 31 AUG 2016 | DOI: 10.1111/bju.13620

    13. Routinely reported ‘equivocal’ lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes

      Elena Galiabovitch, Christopher M. Hovens, Justin S. Peters, Anthony J. Costello, Shane Battye, Sam Norden, Andrew Ryan and Niall M. Corcoran

      Version of Record online: 31 AUG 2016 | DOI: 10.1111/bju.13594

    14. Selective arterial clamping does not improve outcomes in robot-assisted partial nephrectomy: a propensity-score analysis of patients without impaired renal function

      David J. Paulucci, Daniel C. Rosen, John P. Sfakianos, Michael J. Whalen, Ronney Abaza, Daniel D. Eun, Louis S. Krane, Ashok K. Hemal and Ketan K. Badani

      Version of Record online: 31 AUG 2016 | DOI: 10.1111/bju.13614

    15. You have full text access to this OnlineOpen article
      Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer

      Erik N. Mayer, Jonathan D. Tward, Mitchell Bassett, Sara M. Lenherr, James M. Hotaling, William O. Brant, William T. Lowrance and Jeremy B. Myers

      Version of Record online: 30 AUG 2016 | DOI: 10.1111/bju.13607

    16. Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance

      Mufaddal M. Mamawala, Karthik Rao, Patricia Landis, Jonathan I. Epstein, Bruce J. Trock, Jeffrey J. Tosoian, Kenneth J. Pienta and H. Ballentine Carter

      Version of Record online: 29 AUG 2016 | DOI: 10.1111/bju.13608

  6. Reviews

    1. Role of biobanking in urology: a review

      Heather J. Chalfin, Elizabeth Fabian, Leslie Mangold, David B. Yeater, Kenneth J. Pienta and Alan W. Partin

      Version of Record online: 29 AUG 2016 | DOI: 10.1111/bju.13606

  7. Original Articles

    1. ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer

      Jon D. Emery, Michael Jefford, Madeleine King, Dickon Hayne, Andrew Martin, Juanita Doorey, Amelia Hyatt, Emily Habgood, Tee Lim, Cynthia Hawks, Marie Pirotta, Lyndal Trevena and Penelope Schofield

      Version of Record online: 29 AUG 2016 | DOI: 10.1111/bju.13593

    2. A 22-year retrospective study: educational update and new referral pattern of age at orchidopexy

      Yi Wei, Sheng-de Wu, Yang-cai Wang, Tao Lin, Da-wei He, Xu-liang Li, Jun-hong Liu, Xing Liu, Yi Hua, Peng Lu, De-ying Zhang, Sheng Wen and Guang-hui Wei

      Version of Record online: 28 AUG 2016 | DOI: 10.1111/bju.13588

    3. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study

      Tommy K. Nielsen, Brunolf W. Lagerveld, Francis Keeley, Giovanni Lughezzani, Seshadri Sriprasad, Neil J. Barber, Lars U. Hansen, Nicole M. Buffi, Giorgio Guazzoni, Johan A. van der Zee, Mohamed Ismail, Khaled Farrag, Amr M. Emara, Lars Lund, Øyvind Østraat and Michael Borre

      Version of Record online: 26 AUG 2016 | DOI: 10.1111/bju.13615

    4. Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men

      Benjamin V. Stone, Jonathan Shoag, Joshua A. Halpern, Sameer Mittal, Patrick Lewicki, David M. Golombos, Dina Bedretdinova, Bilal Chughtai, Christopher E. Barbieri and Richard K. Lee

      Version of Record online: 23 AUG 2016 | DOI: 10.1111/bju.13613

    5. Cyclooxygenase-2 (COX-2) inhibition for prostate cancer chemoprevention: double-blind randomised study of pre-prostatectomy celecoxib or placebo

      Jason F. Flamiatos, Tomasz M. Beer, Julie N. Graff, Kristine M. Eilers, Wei Tian, Harman S. Sekhon and Mark Garzotto

      Version of Record online: 23 AUG 2016 | DOI: 10.1111/bju.13612

    6. Comparison of spinal cord contusion and transection: functional and histological changes in the rat urinary bladder

      Benjamin N. Breyer, Thomas M. Fandel, Amjad Alwaal, E. Charles Osterberg, Alan W. Shindel, Guiting Lin, Emil A. Tanagho and Tom F. Lue

      Version of Record online: 23 AUG 2016 | DOI: 10.1111/bju.13591

  8. Reviews

    1. The potential role of unregulated autonomous bladder micromotions in urinary storage and voiding dysfunction; overactive bladder and detrusor underactivity

      Marcus J. Drake, Anthony Kanai, Dominika A. Bijos, Youko Ikeda, Irina Zabbarova, Bahareh Vahabi and Christopher H. Fry

      Version of Record online: 23 AUG 2016 | DOI: 10.1111/bju.13598

  9. Original Articles

    1. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia

      Homayoun Zargar, Roderick van den Bergh, Daniel Moon, Nathan Lawrentschuk, Anthony Costello and Declan Murphy

      Version of Record online: 22 AUG 2016 | DOI: 10.1111/bju.13602

  10. Guidelines

    1. You have free access to this content
  11. Reviews

    1. Liquid biopsy: ready to guide therapy in advanced prostate cancer?

      Miriam Hegemann, Arnulf Stenzl, Jens Bedke, Kim N. Chi, Peter C. Black and Tilman Todenhöfer

      Version of Record online: 19 AUG 2016 | DOI: 10.1111/bju.13586

  12. Original Articles

    1. Accuracy of ultrasonography for renal stone detection and size determination: is it good enough for management decisions?

      Vishnu Ganesan, Shubha De, Daniel Greene, Fabio Cesar Miranda Torricelli and Manoj Monga

      Version of Record online: 17 AUG 2016 | DOI: 10.1111/bju.13605

    2. Preliminary experience using a tunica vaginalis flap as the dorsal component of Bracka's urethroplasty

      Luke Harper, Jean-Luc Michel and Frederique Sauvat

      Version of Record online: 17 AUG 2016 | DOI: 10.1111/bju.13604

    3. Urethral diverticulectomy with Martius labial fat pad interposition improves symptom resolution and reduces recurrence

      Sachin Malde, Néha Sihra, Sahar Naaseri, Marco Spilotros, Eskinder Solomon, Mahreen Pakzad, Rizwan Hamid, Jeremy L. Ockrim and Tamsin J. Greenwell

      Version of Record online: 17 AUG 2016 | DOI: 10.1111/bju.13579

    4. You have full text access to this OnlineOpen article
      Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life

      Athene Lane, Chris Metcalfe, Grace J. Young, Tim J. Peters, Jane Blazeby, Kerry N. L. Avery, Daniel Dedman, Liz Down, Malcolm D. Mason, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan and for the ProtecT Study group

      Version of Record online: 17 AUG 2016 | DOI: 10.1111/bju.13582

    5. Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model

      James Liu, Caleb Abshire, Connor Carry, Andrew B. Sholl, Sree Harsha Mandava, Amrita Datta, Manish Ranjan, Cameron Callaghan, Donna V. Peralta, Kristen S. Williams, Weil R. Lai, Asim B. Abdel-Mageed, Matthew Tarr and Benjamin R. Lee

      Version of Record online: 17 AUG 2016 | DOI: 10.1111/bju.13590

    6. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men

      Frans M.J. Debruyne, Hermann M. Behre, Claus G. Roehrborn, Mario Maggi, Frederick C.W. Wu, Fritz H. Schröder, Thomas Hugh Jones, Hartmut Porst, Geoffrey Hackett, Olivia A. Wheaton, Antonio Martin-Morales, Eric Meuleman, Glenn R. Cunningham, Hozefa A. Divan, Raymond C. Rosen and for the RHYME Investigators

      Version of Record online: 14 AUG 2016 | DOI: 10.1111/bju.13578

    7. Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib

      Benoit Beuselinck, Johnny Jean-Baptiste, Patrick Schöffski, Gabrielle Couchy, Clément Meiller, Frederic Rolland, Yves Allory, Steven Joniau, Virginie Verkarre, Reza Elaidi, Evelyne Lerut, Tania Roskams, Jean-Jacques Patard, Stephane Oudard, Arnaud Méjean, Diether Lambrechts and Jessica Zucman-Rossi

      Version of Record online: 12 AUG 2016 | DOI: 10.1111/bju.13585

    8. Predicting complications in partial nephrectomy for T1a tumours: does approach matter?

      Daniel Ramirez, Matthew J. Maurice, Peter A. Caputo, Ryan J. Nelson, Önder Kara, Ercan Malkoç and Jihad H. Kaouk

      Version of Record online: 11 AUG 2016 | DOI: 10.1111/bju.13583

    9. Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer

      Ben Y. Zhang, Shaun M. Riska, Douglas W. Mahoney, Brian A. Costello, Rhea Kohli, Jorge F. Quevedo, James R. Cerhan and Manish Kohli

      Version of Record online: 6 AUG 2016 | DOI: 10.1111/bju.13584

    10. Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities

      Sami-Ramzi Leyh-Bannurah, Hiba Abou-Haidar, Paolo Dell'Oglio, Jonas Schiffmann, Zhe Tian, Hans Heinzer, Hartwig Huland, Markus Graefen, Lars Budäus and Pierre I. Karakiewicz

      Version of Record online: 5 AUG 2016 | DOI: 10.1111/bju.13570

    11. You have free access to this content
      Comparison of robot-assisted and open partial nephrectomy for completely endophytic renal tumours: a single centre experience

      Onder Kara, Matthew J. Maurice, Ercan Malkoc, Daniel Ramirez, Ryan J. Nelson, Peter A. Caputo, Robert J. Stein and Jihad H. Kaouk

      Version of Record online: 1 AUG 2016 | DOI: 10.1111/bju.13572

    12. Contemporary retroperitoneal lymph node dissection (RPLND) for testis cancer in the UK – a national study

      Hannah Wells, Matthew C. Hayes, Tim O'Brien and Sarah Fowler

      Version of Record online: 30 JUL 2016 | DOI: 10.1111/bju.13569

    13. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era

      Jeffrey J. Tosoian, Meera Chappidi, Zhaoyong Feng, Elizabeth B. Humphreys, Misop Han, Christian P. Pavlovich, Jonathan I. Epstein, Alan W. Partin and Bruce J. Trock

      Version of Record online: 29 JUL 2016 | DOI: 10.1111/bju.13573

  13. Supplement Articles

    1. Active surveillance is suitable for intermediate term follow-up of renal oncocytoma diagnosed by percutaneous core biopsy

      Shuo Liu, Stephen Lee, Prem Rashid, Haider Bangash, Akhlil Hamid, Jason Lau and Ronald Cohen

      Version of Record online: 26 JUL 2016 | DOI: 10.1111/bju.13538

  14. Original Articles

    1. What is the outcome of paediatric gastrocystoplasty when the patients reach adulthood?

      Romain Boissier, Eugenie Di Crocco, Alice Faure, Geraldine Hery, Véronique Delaporte, Eric Lechevallier, Pierre D. E. Mouriquand, Jean-Michel Guys and Gilles Karsenty

      Version of Record online: 24 JUL 2016 | DOI: 10.1111/bju.13558


    1. You have free access to this content
      Prostate Imaging Reporting and Data System score of four or more: active surveillance no more

      Marlon Perera, Nikolas Katelaris, Declan G Murphy, Shannon McGrath and Nathan Lawrentschuk

      Version of Record online: 22 JUL 2016 | DOI: 10.1111/bju.13562

  16. Original Articles

    1. Treatment patterns, testicular loss and disparities in inpatient surgical management of testicular torsion in boys: a population-based study 1998–2010

      Akshay Sood, Hanhan Li, Kristina D. Suson, Kaustav Majumder, Mai Sedki, Firas Abdollah, Jesse D. Sammon, Ariella Friedman, Björn Löppenberg, Yegappan Lakshmanan, Quoc-Dien Trinh and Jack S. Elder

      Version of Record online: 19 JUL 2016 | DOI: 10.1111/bju.13557

    2. The origins of urinary stone disease: upstream mineral formations initiate downstream Randall's plaque

      Ryan S. Hsi, Krishna Ramaswamy, Sunita P. Ho and Marshall L. Stoller

      Version of Record online: 14 JUL 2016 | DOI: 10.1111/bju.13555

    3. Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

      Jay D. Raman, Yu-Kuan Lin, Shahrokh F. Shariat, Laura-Maria Krabbe, Vitaly Margulis, Alex Arnouk, Costas D. Lallas, Edouard J. Trabulsi, Sarah J. Drouin, Morgan Rouprêt, Gregory Bozzini, Pierre Colin, Benoit Peyronnet, Karim Bensalah, Kari Bailey, David Canes and Tobias Klatte

      Version of Record online: 10 JUL 2016 | DOI: 10.1111/bju.13556

    4. You have full text access to this OnlineOpen article
      Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)

      Lazaros Andronis, Ilias Goranitis, Sarah Pirrie, Ann Pope, Darren Barton, Stuart Collins, Adam Daunton, Duncan McLaren, Joe M. O'Sullivan, Chris Parker, Emilio Porfiri, John Staffurth, Andrew Stanley, James Wylie, Sharon Beesley, Alison Birtle, Janet E. Brown, Prabir Chakraborti, Syed A. Hussain, J. Martin Russell, Lucinda J. Billingham and Nicholas D. James

      Version of Record online: 10 JUL 2016 | DOI: 10.1111/bju.13549

    5. Socioeconomic factors and penile cancer risk and mortality; a population-based study

      Christian Torbrand, Annette Wigertz, Linda Drevin, Yasin Folkvaljon, Mats Lambe, Ulf Håkansson and Peter Kirrander

      Version of Record online: 4 JUL 2016 | DOI: 10.1111/bju.13534

    6. Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study

      Tiago M. de Carvalho, Eveline A.M. Heijnsdijk and Harry J. de Koning

      Version of Record online: 26 JUN 2016 | DOI: 10.1111/bju.13542

    7. Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels

      Jason C. Chandrapal, Spencer Nielson, Darshan P. Patel, Chong Zhang, Angela P. Presson, William O. Brant, Jeremy B. Myers and James M. Hotaling

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/bju.13546

    8. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?

      Alexander Winter, Eunice Sirri, Lina Jansen, Friedhelm Wawroschek, Joachim Kieschke, Felipe A. Castro, Agne Krilaviciute, Bernd Holleczek, Katharina Emrich, Annika Waldmann, Hermann Brenner and for the Association of Population-based Cancer Registries in Germany (GEKID) Cancer Survival Working Group

      Version of Record online: 20 JUN 2016 | DOI: 10.1111/bju.13537

    9. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer

      Pim J. van Leeuwen, Louise Emmett, Bao Ho, Warick Delprado, Francis Ting, Quoc Nguyen and Phillip D. Stricker

      Version of Record online: 18 JUN 2016 | DOI: 10.1111/bju.13540

    10. Robot-assisted partial cystectomy: perioperative outcomes and early oncological efficacy

      David M. Golombos, Padraic O'Malley, Patrick Lewicki, Benjamin V. Stone and Douglas S. Scherr

      Version of Record online: 15 JUN 2016 | DOI: 10.1111/bju.13535

    11. Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project.

      Rodolfo Hurle, Luisa Pasini, Massimo Lazzeri, Piergiuseppe Colombo, NicolòMaria Buffi, Giovanni Lughezzani, Paolo Casale, Emanuela Morenghi, Roberto Peschechera, Silvia Zandegiacomo, Alessio Benetti, Alberto Saita, Pasquale Cardone and Giorgio Guazzoni

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/bju.13536

    12. Robot-assisted vs open adrenalectomy: evaluation of cost-effectiveness and peri-operative outcome

      Kai Alexander Probst, Carsten-Henning Ohlmann, Matthias Saar, Stefan Siemer, Michael Stöeckle and Martin Janssen

      Version of Record online: 10 JUN 2016 | DOI: 10.1111/bju.13529


    1. You have free access to this content
      Getting personal with prostate cancer: DNA-repair defects and olaparib in metastatic prostate cancer

      Nicholas Raison, Oussama Elhage and Prokar Dasgupta

      Version of Record online: 9 JUN 2016 | DOI: 10.1111/bju.13522

  18. Functional Urology

    1. Evaluation and establishment of a ward-based geriatric liaison service for older urological surgical patients: Proactive care of Older People undergoing Surgery (POPS)-Urology

      Philip Braude, Anna Goodman, Tania Elias, Gordana Babic-Illman, Ben Challacombe, Danielle Harari and Jugdeep K. Dhesi

      Version of Record online: 4 JUN 2016 | DOI: 10.1111/bju.13526

  19. Original Articles

    1. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy

      Uday Patel, Prokar Dasgupta, Ben Challacombe, Declan Cahill, Christian Brown, Roshnee Patel and Roger Kirby

      Version of Record online: 3 JUN 2016 | DOI: 10.1111/bju.13525

    2. You have full text access to this OnlineOpen article
      Quality Improvement in Cystectomy Care with Enhanced Recovery (QUICCER) study

      Janet E. Baack Kukreja, Maureen Kiernan, Bethany Schempp, Aisha Siebert, Adriana Hontar, Benjamin Nelson, James Dolan, Katia Noyes, Ann Dozier, Ahmed Ghazi, Hani H. Rashid, Guan Wu and Edward M. Messing

      Version of Record online: 3 JUN 2016 | DOI: 10.1111/bju.13521

    3. Urethral-fixation technique improves early urinary continence recovery in patients who undergo retropubic radical prostatectomy

      Vincenzo Ficarra, Alessandro Crestani, Marta Rossanese, Vito Palumbo, Mattia Calandriello, Giacomo Novara, Silvio Praturlon and Gianluca Giannarini

      Version of Record online: 2 JUN 2016 | DOI: 10.1111/bju.13514

    4. Magnetic resonance microscopy may enable distinction between normal histomorphological features and prostate cancer in the resected prostate gland

      Matthieu Durand, Manu Jain, Brian Robinson, Eric Aronowitz, Youssef El Douahy, Robert Leung, Douglas S. Scherr, Amelia Ng, Dominique Donzeau, Jean Amiel, Pascal Spincemaille, Arnauld Villers and Douglas J. Ballon

      Version of Record online: 1 JUN 2016 | DOI: 10.1111/bju.13523


    1. You have free access to this content
      If the robot is there, why not use it? Why we should use the robot for laparoscopic nephrectomy

      Wayne Lam, Mollika Chakravorty and Ben Challacombe

      Version of Record online: 29 MAY 2016 | DOI: 10.1111/bju.13509

  21. Original Articles

    1. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer

      Andrei Fodor, Genoveffa Berardi, Claudio Fiorino, Maria Picchio, Elena Busnardo, Margarita Kirienko, Elena Incerti, Italo Dell'Oca, Cesare Cozzarini, Paola Mangili, Marcella Pasetti, Riccardo Calandrino, Luigi Gianolli and Nadia G Di Muzio

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/bju.13510

    2. Detecting positive surgical margins: utilisation of light-reflectance spectroscopy on ex vivo prostate specimens

      Aaron H. Lay, Xinlong Wang, Monica S. C. Morgan, Payal Kapur, Hanli Liu, Claus G. Roehrborn and Jeffrey A. Cadeddu

      Version of Record online: 20 MAY 2016 | DOI: 10.1111/bju.13503

    3. Results of a randomized, double-blind, active-controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder

      Jing Leng, Limin Liao, Ben Wan, Chuanjun Du, Wei Li, Keji Xie, Zhoujun Shen, Zhuoqun Xu, Shiliang Wu, Zujun Fang, Lulin Ma, Shaomei Han, Cornelia Feustel, Yong Yang and Helmut Madersbacher

      Version of Record online: 13 MAY 2016 | DOI: 10.1111/bju.13500

    4. Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma

      Zachary Hamilton, Hak J. Lee, Juan Jimenez, Brian R. Lane, Song Wang, Alp T. Beksac, Kyle Gillis, Amy Alagh, Conrad Tobert, James M. Randall, Christopher J. Kane, Frederick Millard, Steven C. Campbell and Ithaar H. Derweesh

      Version of Record online: 11 MAY 2016 | DOI: 10.1111/bju.13490

    5. Chromogranin A and neurone-specific enolase serum levels as predictors of treatment outcome in patients with metastatic castration-resistant prostate cancer undergoing abiraterone therapy

      Matthias M. Heck, Markus A. Thaler, Sebastian C. Schmid, Anna-Katharina Seitz, Robert Tauber, Hubert Kübler, Tobias Maurer, Mark Thalgott, Georgios Hatzichristodoulou, Michael Höppner, Roman Nawroth, Peter B. Luppa, Jürgen E. Gschwend and Margitta Retz

      Version of Record online: 27 APR 2016 | DOI: 10.1111/bju.13493


    1. You have full text access to this OnlineOpen article
      Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

      Christel Häggström, Pär Stattin, Tanja Stocks, Hans Garmo, Lars Holmberg and Mieke Van Hemelrijck

      Version of Record online: 24 APR 2016 | DOI: 10.1111/bju.13494

  23. Original Articles

    1. You have full text access to this OnlineOpen article
      Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer

      Neal D. Shore, Franklin Chu, Judd Moul, Daniel Saltzstein, Raoul Concepcion, John A. McLane, Stuart Atkinson, Alex Yang and E. David Crawford

      Version of Record online: 16 APR 2016 | DOI: 10.1111/bju.13482

    2. Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare

      Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Keijiro Kiyoshima, Junichi Inokuchi, Katsunori Tatsugami, Ken-ichiro Shiga, Hirofumi Koga, Akito Yamaguchi, Seiji Naito and Masatoshi Eto

      Version of Record online: 6 APR 2016 | DOI: 10.1111/bju.13483

    3. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi-institutional study

      Romain Mathieu, Ilaria Lucca, Mihai D. Vartolomei, Aurélie Mbeutcha, Tobias Klatte, Christian Seitz, Pierre I. Karakiewicz, Harun Fajkovic, Maxine Sun, Yair Lotan, Francesco Montorsi, Alberto Briganti, Morgan Rouprêt, Vitaly Margulis, Michael Rink, Malte Rieken, Lukas Kenner, Martin Susani, Loidl Wolgang and Shahrokh F. Shariat

      Version of Record online: 5 APR 2016 | DOI: 10.1111/bju.13472

    4. You have full text access to this OnlineOpen article
      Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients

      Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi and Tomoaki Miyagawa

      Version of Record online: 1 APR 2016 | DOI: 10.1111/bju.13465

    5. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases

      Yan Shibing, Liu Liangren, Wei Qiang, Liao Hong, Song Turun, Lei Junhao, Yang Lu, Yuan Zhengyong, Jiang Yonghao, Fu Guangqing, Li Yunxiang and Cao Dehong

      Version of Record online: 27 MAR 2016 | DOI: 10.1111/bju.13463


  1. 1 - 100
  2. 101 - 108